Table 2:
Variables | HR (95% CI) | P-value |
---|---|---|
Age (years) (n = 261) | 1.016 (1.01–1.03) | 0.001a |
Grade | ||
Low/intermediate (n = 36) | Ref | |
High (n = 183) | 1.893 (1.09–3.28) | 0.023a |
Pulmonary metastasectomy | ||
No (n = 164) | Ref | |
Yes (n = 55) | 0.536 (0.34–0.85) | 0.008a |
T stageb | ||
T1 (n = 37) | Ref | |
T2/3 (n = 182) | 1.499 (0.86–2.61) | 0.15 |
Chemotherapyc | ||
No/unknown (n = 48) | Ref | |
Yes (n = 171) | 0.569 (0.35–0.92) | 0.021a |
Radiationc | ||
None (n = 163) | Ref | |
Yes (n = 56) | 0.717 (0.47–1.10) | 0.13 |
Frequencies for each variable are indicated. Cases with missing survival data excluded.
Significant.
AJCC 7th edition staging for primary sarcoma.
Adjuvant and/or neoadjuvant with respect to the primary disease.
CI: confidence interval; HR: hazard ratio; Ref: reference variable.